Tekmira suspends Ebola work; changes name, focus

Once one of the hottest Ebola firms investors couldn't get enough of, Tekmira on 20 July said it was suspending its drug development activities in the space and focusing its efforts on hepatitis B virus (HBV) – even changing its company name to Arbutus Biopharma, effective 3 August.